Tom Storey

Tom Storey is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Director of Corporate Development at Jazz Pharmaceuticals. He has over 19 years of experience in business development and strategy within large and mid-cap biopharmaceutical companies. His career includes significant roles at notable firms such as Amgen and Exelixis, where he has successfully led various strategic initiatives and closed numerous high-profile transactions.24

Professional Background

• Current Position: Senior Director of Corporate Development at Jazz Pharmaceuticals.
• Previous Roles:
  • Vice President, Head of Business Development at Angitia Biopharmaceuticals.
  • Led product development teams at Jazz Pharmaceuticals, focusing on advancing innovative drugs through various stages of clinical development.124

Education

Tom Storey holds a robust educational background that includes degrees in biology and business administration, equipping him with the necessary skills to navigate the complex landscape of biopharmaceutical development and commercialization.2

Key Achievements

• At Amgen, he played a pivotal role in the strategy and business development for blockbuster musculoskeletal products, including Prolia and Evenity.
• He has been instrumental in advancing first-in-class small molecule drugs through critical phases of development while at Jazz Pharmaceuticals.23

Tom's extensive experience and leadership in corporate development contribute significantly to Jazz Pharmaceuticals' mission of improving patients' lives through innovative therapies.